Details for New Drug Application (NDA): 204674
✉ Email this page to a colleague
The generic ingredient in ACETYLCYSTEINE is acetylcysteine. There are three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.
Summary for 204674
Tradename: | ACETYLCYSTEINE |
Applicant: | Alvogen |
Ingredient: | acetylcysteine |
Patents: | 0 |
Pharmacology for NDA: 204674
Mechanism of Action | Reduction Activity |
Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Glutathione Concentration |
Medical Subject Heading (MeSH) Categories for 204674
Suppliers and Packaging for NDA: 204674
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 204674 | ANDA | Fresenius Kabi USA, LLC | 63323-691 | 63323-691-30 | 3 VIAL in 1 CARTON (63323-691-30) / 30 mL in 1 VIAL (63323-691-22) |
ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 204674 | ANDA | Fresenius Kabi USA, LLC | 63323-693 | 63323-693-10 | 3 VIAL in 1 CARTON (63323-693-10) / 10 mL in 1 VIAL (63323-693-22) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION, ORAL | Strength | 10% | ||||
Approval Date: | Feb 11, 2014 | TE: | AN | RLD: | No |
Complete Access Available with Subscription